Prelude Therapeutics - Delaware Business Times

Home Tags Prelude Therapeutics

Prelude Therapeutics closes $158M IPO as share value surges

Health Care

Prelude Therapeutics closes $158M IPO as share value surges

Jacob Owens -

September 25, 2020

Prelude Therapeutics sets IPO higher at $150M

Health Care

Prelude Therapeutics sets IPO higher at $150M

Jacob Owens -

September 21, 2020

Prelude Therapeutics plans IPO worth upward of $100M

Health Care

Prelude Therapeutics plans IPO worth upward of $100M

Jacob Owens -

September 8, 2020

Prelude Therapeutics gets $50M Series C funding

Health Care

Prelude Therapeutics gets $50M Series C funding

Jacob Owens -

August 25, 2020

Features

Bioscience startups need support beyond the incubator stage

Editorial -

September 16, 2019

Features

People to Watch in 2019

Editorial -

January 3, 2019

Features

The steady rise of Prelude Therapeutics

Alex Vuocolo -

October 22, 2018

Delaware gives out $3M to 3 businesses for expansion, hiring

Government

Delaware gives out $3M to 3 businesses for expansion, hiring

Alex Vuocolo -

August 16, 2017

Scientist behind Incyte’s Jakafi ready to expand

Delaware Careers

Scientist behind Incyte’s Jakafi ready to expand

Alex Vuocolo -

August 15, 2017

Innovation Delaware

Innovation Delaware Company to Watch: Prelude Therapeutics

Editorial -

July 26, 2017

1 2 34Page 4 of 4

Current Issue